INS and diabetes mellitus: Although it has been established that serum C-peptide is a marker of insulin resistance and obesity, specifically in type 2 diabetes, and basal C-peptide levels are significantly elevated in patients with metabolic syndrome and diabetes [15], more recent studies have reported that serum C-peptide levels are strongly and positively associated with stroke events independent of serum insulin level in people with diabetes [16].